Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
Summary
This condition involves the use of sedative, hypnotic, or anxiolytic substances with an associated psychotic disorder characterized by delusions. The unspecified nature of the use indicates insufficient detail to classify the pattern of use further. These substances are commonly prescribed for anxiety, insomnia, or sedation but may be used in ways that lead to psychotic symptoms, including delusions.
Causes
The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced psychotic disorder with delusions.
Risk Factors
- Prolonged or excessive use of these medications
- History of substance use disorders
- Underlying mental health conditions (e.g., anxiety, depression)
- Easy access to sedative/hypnotic/anxiolytic drugs
- Recreational or non-medical use
Symptoms
- Use of sedative, hypnotic, or anxiolytic substances
- Presence of psychotic symptoms, specifically delusions
- No evidence of dependence, withdrawal, or abuse (unless documented)
- Symptoms may include fixed false beliefs unrelated to cultural norms
Diagnosis
Diagnosis is based on clinical evaluation of substance use history and assessment of psychotic symptoms. The presence of delusions attributed to the substance use, along with the unspecified pattern of use, is key. Clinical judgment is required to confirm the causal relationship between the substance and the psychotic disorder.
Treatment Options
- Discontinuation or reduction of the offending substance, if safe and appropriate
- Antipsychotic medications to manage psychotic symptoms
- Monitoring for withdrawal or dependence, if applicable
- Psychiatric evaluation and ongoing care
Prognosis and Follow-Up
Prognosis depends on the severity of the psychotic disorder, the duration of substance use, and the effectiveness of treatment. Follow-up care may include ongoing psychiatric monitoring, substance use counseling, and medication management to prevent recurrence.
Complications
- Worsening of psychotic symptoms
- Increased risk of self-harm or harm to others
- Potential for substance dependence or withdrawal
- Social or occupational impairment
Lifestyle & Prevention
- Avoid non-prescribed use of sedative, hypnotic, or anxiolytic drugs
- Follow prescribed dosing instructions carefully
- Seek help for substance use concerns early
- Maintain open communication with healthcare providers about medication use
When to Seek Professional Help
Seek immediate medical attention if experiencing severe delusions, hallucinations, or changes in behavior. Contact a healthcare provider for persistent or worsening symptoms, or if substance use is causing distress or impairment.
Tips for Medical Coders
This code requires documentation of both the unspecified sedative, hypnotic, or anxiolytic use and the presence of a sedative, hypnotic, or anxiolytic-induced psychotic disorder with delusions. Ensure clinical notes specify the psychotic symptoms (delusions) and their relationship to the substance use. The unspecified nature of the use should be clearly documented if no further details are available.
Medical Policies and Guidelines
Related policies from health plans
F13.950 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.